HOOMAN NOORCHASHM
Medical Practice in Penn Valley, PA
License number
Pennsylvania MT183538
Category
Medicine
Type
Graduate Medical Trainee
Address
Address
Penn Valley, PA 19072
Professional information
Use Of B Lymphocyte Stimulator Protein Antagonists To Promote Transplantation Tolerance
US Patent:
2011001, Jan 20, 2011
Filed:
Feb 12, 2010
Appl. No.:
12/705551
Inventors:
Thi-Sau Migone - Gaithersburg MD, US
Hooman Noorchashm - Narberth PA, US
Michael Cancro - Media PA, US
Hooman Noorchashm - Narberth PA, US
Michael Cancro - Media PA, US
Assignee:
HUMAN GENOME SCIENCES, INC. - ROCKVILLE MD
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA - PHILADELPHIA PA
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA - PHILADELPHIA PA
International Classification:
A61K 39/395, A61K 38/16, A61K 38/13, A61P 37/06
US Classification:
4241331, 514 212, 4241731, 4241391, 514 205
Abstract:
The invention relates to methods of preventing, treating, ameliorating and otherwise inhibiting organ or transplant rejection in a patient by administering B Lymphocyte Stimulator antagonists. In addition, therapeutic treatment regimens are provided to promote transplant tolerance in a patient following the administration of B Lymphocyte Stimulatorantagonists.
Screening For Cd93 (C1Qrp)-Associated Polymorphism(S) In The Diagnosis, Prevention And Treatment Of Autoimmune Diseases
US Patent:
2011001, Jan 20, 2011
Filed:
Dec 19, 2007
Appl. No.:
12/520515
Inventors:
Hooman Noorchashm - Narberth PA, US
Ali Naji - North Wales PA, US
Ali Naji - North Wales PA, US
Assignee:
THE TRUSTEES OF THE UNIVESITY OF PENNSYLVANIA - Philidelphia PA
International Classification:
C12Q 1/68, C07H 21/04, C07H 21/00, C12N 15/63, C07K 14/705, C07K 16/28, G01N 33/566
US Classification:
435 6, 536 235, 536 231, 4353201, 530396, 5303879, 435 724
Abstract:
This invention is directed to a marker gene for autoimmune disease. Specifically, the invention is directed to the use of a polymorph of CD93 in methods and compositions for the detection, prognosis and therapy of Type I Diabetes and systemic lupus erythematosus (SLE).